COG-401

N/A

Report date: 2024/09/18 10:42:14

Base Information

Drug NameCOG-401
Drug Alias NameCOG-401
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsNerve Degeneration
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCognigenics Inc
China Registration ClassN/A

Develop Information

Active CompaniesCognigenics Inc
Inactive CompaniesN/A
Active IndicationsNerve Degeneration
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A